Format

Send to

Choose Destination
Curr Opin Virol. 2015 Oct;14:116-28. doi: 10.1016/j.coviro.2015.08.016. Epub 2015 Sep 29.

Kaposi Sarcoma-associated Herpesvirus: mechanisms of oncogenesis.

Author information

1
Institute of Virology, Hannover Medical School, Hannover, Germany; German Centre of Infection Research, Hannover-Braunschweig Site, Hannover, Germany. Electronic address: schulz.thomas@mh-hannover.de.
2
Department of Pathology and Laboratory Medicine, Weill Cornell Medical College, New York, USA. Electronic address: ecesarm@med.cornell.edu.

Abstract

Kaposi Sarcoma-associated Herpesvirus (KSHV, HHV8) causes three human malignancies, Kaposi Sarcoma (KS), an endothelial tumor, as well as Primary Effusion Lymphoma (PEL) and the plasma cell variant of Multicentric Castleman's Disease (MCD), two B-cell lymphoproliferative diseases. All three cancers occur primarily in the context of immune deficiency and/or HIV infection, but their pathogenesis differs. KS most likely results from the combined effects of an endotheliotropic virus with angiogenic properties and inflammatory stimuli and thus represents an interesting example of a cancer that arises in an inflammatory context. Viral and cellular angiogenic and inflammatory factors also play an important role in the pathogenesis of MCD. In contrast, PEL represents an autonomously growing malignancy that is, however, still dependent on the continuous presence of KSHV and the action of several KSHV proteins.

PMID:
26431609
DOI:
10.1016/j.coviro.2015.08.016
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center